Filing Details
- Accession Number:
- 0001645113-21-000106
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-07 16:32:50
- Reporting Period:
- 2021-09-02
- Accepted Time:
- 2021-09-07 16:32:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645113 | Novocure Ltd | NVCR | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1744884 | Pritesh Shah | C/O Novocure Inc., 20 Valley Stream Parkway, Suite 300 Malvern PA 19355 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2021-09-02 | 156 | $138.23 | 74,013 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2021-09-03 | 321 | $138.27 | 73,692 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2021-09-03 | 150 | $139.24 | 73,542 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2021-09-03 | 30 | $140.18 | 73,512 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- On September 3, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 321 shares in multiple trades at prices ranging from $137.75 to $138.56. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- On September 3, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 150 shares in multiple trades at prices ranging from $138.81 to $139.78. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah.
Billionaire Hedge Funds
